LakeShore Biopharma Updates Corporate Framework

LakeShore Biopharma (LSB) has released an update.

LakeShore Biopharma Co., Ltd has announced an update to its corporate structure with a Second Amended and Restated Memorandum and Articles of Association, effective October 1, 2024. This legal and administrative move includes a reconfirmation of the company’s unrestricted business objectives, the flexibility to manage its share capital, and the ability to engage in international business operations, while specifying that the company will not trade within the Cayman Islands except in support of its external business activities.

For further insights into LSB stock, check out TipRanks’ Stock Analysis page.